These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10792454)

  • 1. Protection against dopaminergic nigrostriatal cell death by excitatory input ablation.
    Takada M; Matsumura M; Kojima J; Yamaji Y; Inase M; Tokuno H; Nambu A; Imai H
    Eur J Neurosci; 2000 May; 12(5):1771-80. PubMed ID: 10792454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the pedunculopontine tegmental nucleus in experimental parkinsonism in primates.
    Matsumura M; Kojima J
    Stereotact Funct Neurosurg; 2001; 77(1-4):108-15. PubMed ID: 12378066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excitotoxic lesions of the pedunculopontine tegmental nucleus produce contralateral hemiparkinsonism in the monkey.
    Kojima J; Yamaji Y; Matsumura M; Nambu A; Inase M; Tokuno H; Takada M; Imai H
    Neurosci Lett; 1997 Apr; 226(2):111-4. PubMed ID: 9159502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication.
    Rolland AS; Tandé D; Herrero MT; Luquin MR; Vazquez-Claverie M; Karachi C; Hirsch EC; François C
    J Neurochem; 2009 Aug; 110(4):1321-9. PubMed ID: 19527435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that non-NMDA receptors are involved in the excitatory pathway from the pedunculopontine region to nigrostriatal dopaminergic neurons.
    Di Loreto S; Florio T; Scarnati E
    Exp Brain Res; 1992; 89(1):79-86. PubMed ID: 1351000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.
    Schneider JS; Yuwiler A; Markham CH
    Brain Res; 1987 May; 411(1):144-50. PubMed ID: 2886180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-MPTP treatment with granulocyte colony-stimulating factor improves nigrostriatal function in the mouse model of Parkinson's disease.
    McCollum M; Ma Z; Cohen E; Leon R; Tao R; Wu JY; Maharaj D; Wei J
    Mol Neurobiol; 2010 Jun; 41(2-3):410-9. PubMed ID: 20405343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.
    Kozina EA; Khakimova GR; Khaindrava VG; Kucheryanu VG; Vorobyeva NE; Krasnov AN; Georgieva SG; Kerkerian-Le Goff L; Ugrumov MV
    J Neurol Sci; 2014 May; 340(1-2):198-207. PubMed ID: 24768159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a rhesus monkey model of Parkinson's disease.
    Li H; He Z; Su T; Ma Y; Lu S; Dai C; Sun M
    Neurol Res; 2003 Apr; 25(3):263-7. PubMed ID: 12739234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
    Sconce MD; Churchill MJ; Greene RE; Meshul CK
    Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
    Bensaid M; Michel PP; Clark SD; Hirsch EC; François C
    Exp Neurol; 2016 Jan; 275 Pt 1():209-19. PubMed ID: 26571193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astroglial ablation prevents MPTP-induced nigrostriatal neuronal death.
    Takada M; Li ZK; Hattori T
    Brain Res; 1990 Feb; 509(1):55-61. PubMed ID: 2306638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation.
    Betarbet R; Porter RH; Greenamyre JT
    J Neurochem; 2000 Mar; 74(3):1166-74. PubMed ID: 10693949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pedunculopontine nucleus in the squirrel monkey: cholinergic and glutamatergic projections to the substantia nigra.
    Lavoie B; Parent A
    J Comp Neurol; 1994 Jun; 344(2):232-41. PubMed ID: 7915727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems.
    Grabli D; Karachi C; Folgoas E; Monfort M; Tande D; Clark S; Civelli O; Hirsch EC; François C
    J Neurosci; 2013 Jul; 33(29):11986-93. PubMed ID: 23864685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamatergic and cholinergic inputs from the pedunculopontine tegmental nucleus to dopamine neurons in the substantia nigra pars compacta.
    Futami T; Takakusaki K; Kitai ST
    Neurosci Res; 1995 Feb; 21(4):331-42. PubMed ID: 7777224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.
    Fuxe K; Janson AM; Rosén L; Finnman UB; Tanganelli S; Morari M; Goldstein M; Agnati LF
    Exp Brain Res; 1992; 88(1):117-30. PubMed ID: 1347270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.